COVID-19患者血小板基因表达与功能研究
本研究探讨SARS-CoV-2感染对血小板基因表达和功能的影响。RNA测序显示COVID-19患者循环血小板基因表达谱发生明显改变,涉及蛋白泛素化、抗原提呈和线粒体功能障碍等通路;血小板未检测到ACE2的mRNA或蛋白,但25例患者中2例血小板检出SARS-CoV-2 N1基因mRNA。患者静息及活化后P-选择素表达增加,血小板-中性粒细胞、-单核细胞、-T细胞聚集体均显著高于健康供者,血小板聚集更快且在纤维蛋白原和胶原上铺展增加,部分归因于MAPK通路活化和血栓素生成增加。
要点
- COVID-19患者循环血小板基因表达谱发生明显改变,涉及蛋白泛素化、抗原提呈和线粒体功能障碍通路。
- 患者血小板未检测到ACE2的mRNA或蛋白,但25例中2例检出SARS-CoV-2 N1基因mRNA。
- 患者血小板静息及活化后P-选择素表达增加,血小板-中性粒细胞、-单核细胞、-T细胞聚集体均显著高于健康供者。
核心结论
- SARS-CoV-2感染与血小板高反应性相关,可能参与COVID-19的病理生理过程。
研究设计与样本
- 研究纳入COVID-19患者,对循环血小板进行RNA测序、基因表达谱分析及功能实验,并与健康供者比较。
主要发现
- RNA测序显示COVID-19患者循环血小板基因表达谱发生明显改变,通路分析显示蛋白泛素化、抗原提呈和线粒体功能障碍相关通路存在差异表达变化。
- 血小板未检测到ACE2的mRNA或蛋白;25例COVID-19患者中2例血小板检出SARS-CoV-2 N1基因mRNA。
- COVID-19患者静息血小板P-选择素基础表达及活化后表达均增加。
- COVID-19患者循环血小板-中性粒细胞、-单核细胞、-T细胞聚集体均显著高于健康供者。
- COVID-19患者血小板聚集更快,在纤维蛋白原和胶原上铺展增加;血小板活化和聚集增加可部分归因于MAPK通路活化及血栓素生成增加。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
There is an urgent need to understand the pathogenesis of coronavirus disease 2019 (COVID-19). In particular, thrombotic complications in patients with COVID-19 are common and contribute to organ failure and mortality. Patients with severe COVID-19 present with hemostatic abnormalities that mimic disseminated intravascular coagulopathy associated with sepsis, with the major difference being increased risk of thrombosis rather than bleeding. However, whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection alters platelet function to contribute to the pathophysiology of COVID-19 remains unknown. In this study, we report altered platelet gene expression and functional responses in patients infected with SARS-CoV-2. RNA sequencing demonstrated distinct changes in the gene-expression profile of circulating platelets of COVID-19 patients. Pathway analysis revealed differential gene-expression changes in pathways associated with protein ubiquitination, antigen presentation, and mitochondrial dysfunction. The receptor for SARS-CoV-2 binding, angiotensin-converting enzyme 2 (ACE2), was not detected by messenger RNA (mRNA) or protein in platelets. Surprisingly, mRNA from the SARS-CoV-2 N1 gene was detected in platelets from 2 of 25 COVID-19 patients, suggesting that platelets may take-up SARS-COV-2 mRNA independent of ACE2. Resting platelets from COVID-19 patients had increased P-selectin expression basally and upon activation. Circulating platelet-neutrophil, -monocyte, and -T-cell aggregates were all significantly elevated in COVID-19 patients compared with healthy donors. Furthermore, platelets from COVID-19 patients aggregated faster and showed increased spreading on both fibrinogen and collagen. The increase in platelet activation and aggregation could partially be attributed to increased MAPK pathway activation and thromboxane generation. These findings demonstrate that SARS-CoV-2 infection is associated with platelet hyperreactivity, which may contribute to COVID-19 pathophysiology.
引用
- Manne BK, Denorme F, Middleton EA, et al. Platelet gene expression and function in patients with COVID-19. Blood. 2020. PMID: 32573711. doi:10.1182/blood.2020007214
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。